What is I-SPY?
The I-SPY series of trials are changing the way new treatments are developed for breast cancer, helping make available new, better and more personalized treatments, faster. At the heart of the I-SPY program is the ground-breaking I-SPY 2 platform trial for neoadjuvant treatment of locally advanced breast cancer.
1400
patients enrolled
16
agents completed
evaluation since 2010
3
agents received
accelerated approval
